DEA Archived Press Releases

Press Releases before January 20, 2025
1913 Results - Showing 1331 to 1340
PRESS RELEASE

Waterbury Man Pleads Guilty To Heroin Charge Stemming From Overdose Death In Winsted

BRIDGEPORT, Conn. - Peter Haskell, 32, of Waterbury, waived his right to be indicted and pleaded guilty yesterday before U.S. District Judge Victor A. Bolden in Bridgeport to one count of possession with intent to distribute, and distribution of, heroin. Michael J. Ferguson Special Agent in Charge of the DEA’s...
PRESS RELEASE

CVS Pharmacy Inc. Pays $5m To Settle Alleged Violations Of The Controlled Substance Act

SACRAMENTO, Calif. - CVS Pharmacy Inc. has paid $5 million to resolve federal Controlled Substances (CSA) allegations that its pharmacies in the Eastern District of California failed to keep and maintain accurate records of Schedule II, III, IV, and V controlled substances, U.S. Attorney Phillip A. Talbert and Drug Enforcement...
PRESS RELEASE

Heroin Dealer Sentenced To Over 8 Years For Distributing Heroin Connected To Overdose Death

MANHATTAN, N.Y. - Anthony de LosAngeles, aka “Taco,” 20, of Tarrytown, New York, was sentenced today to over eight years in prison for selling heroin, some of which substantially contributed to the overdose death of one of de LosAngeles’s customers. De LosAngeles pled guilty on March 17, 2017, to one...
PRESS RELEASE

Man Sentenced In Alabama For Nine Pharmacy Burglaries

MOBILE, Ala. - Elyric Nathaniel Singleton, III was sentenced today by a Senior United States District Judge to 97 months in federal prison for his role in nine pharmacy burglaries, announced Drug Enforcement (DEA) Special Agent in Charge Stephen G. Azzam and Acting United States Attorney Steve Butler of the...
PRESS RELEASE

Opiate Overdoses Surpass Murders In New Orleans For First Time

NEW ORLEANS - The number of accidental drug-related overdose deaths in the City of New Orleans in 2016 exceeded the number of murders for the first time in the city’s history, according to the Orleans Parish Coroner’s Office. Drug-related deaths in Orleans Parish totaled 211 in 2016, more than double...
PRESS RELEASE

Member Of Violent Grape Street Crips Gang Admits Witness Intimidation As Part Of Racketeering Conspiracy

NEWARK, N.J. - Carl J. Kotowski, Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division, and William E. Fitzpatrick, Acting U.S. Attorney for the District of New Jersey announced a member of the New Jersey set of the Grape Street Crips today admitted his role in a...
PRESS RELEASE

Bergen County Man Sentenced To 162 Months In Prison For Conspiracy To Distribute More Than Three Kilograms Of Heroin

NEWARK, N.J. - Carl J. Kotowski, Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division and William E. Fitzpatrick, Acting U.S. Attorney for the District of New Jersey, announced a Bergen County, New Jersey, man was sentenced today to 162 months in prison for purchasing more than...
PRESS RELEASE

Mallinckrodt Agrees To Pay $35 Million Settlement

WASHINGTON, D.C. - Mallinckrodt LLC, a pharmaceutical manufacturer and one of the largest manufacturers of generic oxycodone, agreed to pay $35 million to settle allegations that it violated certain provisions of the Controlled Substances (CSA) that are subject to civil penalties, Attorney General Jeff Sessions of the Justice Department and...
PRESS RELEASE

DEA Launches CampusDrugPrevention.gov: Targets College Drug Use

WASHINGTON, D.C. - The U.S. Drug Enforcement Administration today launched CampusDrugPrevention.gov, a new website focused on preventing and addressing college drug use. “We must talk to folks about the dangers and consequences of drug abuse, and base those conversations on facts and science,” said DEA Acting Administrator Chuck Rosenberg. “With...
PRESS RELEASE

Mallinckrodt Agrees To Pay $35 Million Record Settlement For Failure To Report Suspicious Orders Of Pharmaceutical Drugs And For Recordkeeping Violations

DETROIT, Mich. - Mallinckrodt LLC, a pharmaceutical manufacturer and one of the largest manufacturers of generic oxycodone, agreed to pay $35 million to settle allegations that it violated certain provisions of the Controlled Substances (CSA) that are subject to civil penalties. Acting United States Attorney Daniel Lemisch and Timothy J...